Impact of age and amyloidosis on thiol conjugation of transthyretin in hereditary transthyretin amyloidosis

Amyloid

Volumn 6, Issue 3, 1999, Pages 187-191

  Suhr, Ole B ^a   Svendsen, Ida Hastrup ^b   Ohlsson, Per Ingvar ^a   Lendoire, Javier ^c   Trigo, Pedro ^c   Tashima, Kazuhiro ^a   Ranløv, Poul J ^d   Ando, Yukio ^e  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b BISPEBJERG HOSPITAL   (Denmark)

^c HOSPITAL GENERAL DE AGUDOS DR COSME ARGERICH   (Argentina)

^d HILLERØD HOSPITAL   (Denmark)

^e KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Amyloidosis genetics; Inborn errors of metabolism; Thiol conjugation chemistry; Transthyretin chemistry

Indexed keywords

PREALBUMIN; THIOL;

ADOLESCENT; ADULT; AGE; AGED; AMYLOIDOSIS; ARTICLE; CONJUGATION; FEMALE; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PROCESSING;

EID: 0346445192     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.3109/13506129909007325     Document Type: Article

References (21)

1. 1 Glenner GG, Eanes ED, Bladen HA, Linke RP and Termine JD (1974). ß-pleated sheet fibrils: a comparison of native amyloid with synthetic protein fibrils. J Histochem Cytochem 22, 1441-1158
2. 2 Benson M and Uemichi T (1996). Transthyretin amyloidosis. Amyloid: Int J Clin Invest 3, 44-56
3. 3 Andersson R (1976). Familial amyloidosis with polyneuropathy: A clinical study based on patients living in northern Sweden. Acta Med Scan 198 (Suppl 590), 1-76
4. 4 Andrade C (1952). A peculiar form of peripheral neuropathy. Familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 75, 408-427
5. 5 Fredriksen T, Harboe N, Kiaer W and Mellemgaard K (1962). Familial primary amyloidosis with severe amyloid heart disease. Am J Med 33, 325-348
6. 6 Ranløv I, Alves IL, Ranløv PJ, Husby G, Costa PP and Saraiva MJM (1992). A Danish kindred with familial amyloid cardiomyopathy revisited: Identification of a mutant transthyretinmethionine 111 variant in serum from patients and carriers. Am J Med 93, 3-8
7. 7 Coutinho P, da Silva AM, Lima JK and Barbosa AR (1979). Forty years of experience with type I amyloid neuropathy. Review of 483 cases. In Glenner GG, Costa PP and de Freitas AF (eds.) Amyloid and amyloidosis ,pp. 88-98 (Póvoa de Varz̧im, Portugal)
8. 8 Araki S (1984). Type I familial amyloidotic polyneuropathy (Japanese type). Brain Dev 6, 128-133
9. 9 Holmgren G, Costa PMP, Andersson C, Asplund K, Steen L, Beckman L, Nylander P-O, Teixeira A, Saraiva MJM and Costa PP (1994). Geographical distribution of TTR met30 carriers in Northern Sweden: discrepancy between carrier frequency and prevalence rate. J Med Genet 31. 351-354
10. 10 Holmgren G, Ando Y, Wikström L, Rydh A and Suhr O (1997). Discordant symptoms in monozygotic twins with familial amyloidotic polyneuropathy (FAP) (TTR met 30). Amyloid: Int J Exp Clin Invest 4, 178-180
11. 11 Ando Y, Ohlsson P-I, Suhr O, Nyhlin N, Yamashita T, Holmgren G, Danielsson A, Sandgren O, Uchino M and Ando M (1996). A new simple and rapid screening method for variant transthyretin (TTR) related amyloidosis. Biochem Biophys Res Commun 228, 480-483
12. 12 Ranløv I, Ando Y, Ohlsson PI, Holmgren G, Ranløv PJ and Suhr OB (1997). Rapid screening for amyloid related variant forms of transthyretin is possible by electrospray ionisation mass spectrometry. Eur J Clin Invest 27, 956-959
13. 13 Kishikawa M, Nakanishi T, Miyazaki A and Shimizu A (1999). A simple and reliable method of detecting variant transthyretins 'by multidimensional liquid chromatography coupled to electrospray ionization mass spectrometry. Amyloid: Int J Exp Clin Invest 6, 48-53
14. 14 Théberge R, Connors L, Skare J, Skinner M, Falk RH and Costello CE (1999). A new amyloidogenic transthyretin variant (Val122Ala) found in a compound heterozygous patient. Amyloid: Int J Exp Clin Invest 6, 54-58
15. 15 Kelly J and Lansbury P (1994). A chemical approach to elucidate the mechanism of transthyretin and ß-protein amyloid fibril formation. Amyloid: Int J Exp Clin Invest 1, 186-205
16. 16 Suhr OB, Ando Y, Ohlsson P-I, Olofsson A, Andersson K, Lundgren E and Ando M (1998). Investigation into thiol conjugation of transthyretin in hereditary transthyretin amyloidosis. Eur J Clin Invest 28, 687-692
17. 17 Anonymous (1989). JMP® User's guide, version 2 of JMP. SAS Institute Inc. Cary, NC, USA. p. 584
18. 18 Era S, Kuwata K, Imai H, Nakamura K, Hayashi T and Sogarni M (1995). Age-related change in redox state of human serum albumin. Biochim Biophys Acta 1247, 12-16
19. 19 Terry CJ, Damas AM, Oliveira P, Saraiva MJ, Alves IL, Costa PP, Matias PM, Sakaki Y and Blake CC (1993). Structure of Met30 variant of transthyretin and its amyloidogenic implications. EMBO J 12, 735-41
20. 20 Ando Y, Gustavsson Å, Suhr O, Ohlsson P-I and Westermark P. Impact of Cys-conjugation and pH on amyloid formation of wild type and Met30 transthyretin (TTR) (1998). Presented at the VIII International Symposium on Amyloidosis, Minnisota, August 7-11, 1998. p. 45
21. 21 Ando Y, Nyhlin N, Suhr O, Holmgren G, Uchida K, El-Salhy M, Yamashita T, Terazaki H, Nakamura M, Uchino M and Ando M (1997). Oxidative stress is found in amyloid deposits, Biochem Biophys Res Commun 232, 497-502